Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Chronic hepatitis B virus (HBV) infection and dietary exposure to aflatoxin B1 (AFB1) are major risk factors for hepatocellular carcinoma (HCC). The aim of this study was to evaluate the role of HBV genetic variation and the R249S mutation of the p53 gene, a marker of AFB1-induced HCC, in Thai patients chronically infected with HBV. Sixty-five patients with and 89 patients without HCC were included. Viral mutations and R249S mutation were characterized by direct sequencing and restriction fragment length polymorphism (RFLP) in serum samples, respectively. The prevalences of T1753C/A/G and A1762T/G1764A mutations in the basal core promotor (BCP) region were significantly higher in the HCC group compared to the non-HCC group. R249S mutation was detected in 6.2% and 3.4% of the HCC and non-HCC groups, respectively, which was not significantly different. By multiple logistic regression analysis, the presence of A1762T/G1764A mutations was independently associated with the risk of HCC in Thai patients.

Original publication

DOI

10.7314/apjcp.2013.14.6.3555

Type

Journal article

Journal

Asian Pacific journal of cancer prevention : APJCP

Publication Date

01/2013

Volume

14

Pages

3555 - 3559

Addresses

Department of Biochemistry, Chulalongkorn University, Bangkok, Thailand.

Keywords

Humans, Hepatitis B virus, Hepatitis B, Chronic, Carcinoma, Hepatocellular, Liver Neoplasms, DNA, Viral, Prognosis, Risk Factors, Case-Control Studies, Follow-Up Studies, Polymerase Chain Reaction, Genotype, Mutation, Polymorphism, Restriction Fragment Length, Adult, Middle Aged, Thailand, Female, Male, Tumor Suppressor Protein p53, Genetic Variation